Teladoc Health (NYSE:TDOC) Shares Down 4.4%

Teladoc Health, Inc. (NYSE:TDOC)’s stock price fell 4.4% during mid-day trading on Tuesday . The company traded as low as $9.86 and last traded at $9.90. 1,751,633 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 4,865,412 shares. The stock had previously closed at $10.36.

Analyst Upgrades and Downgrades

A number of brokerages have issued reports on TDOC. TD Cowen decreased their price target on Teladoc Health from $16.00 to $15.00 and set a “hold” rating for the company in a report on Friday, April 26th. Evercore ISI cut their price objective on Teladoc Health from $15.00 to $14.00 and set an “in-line” rating for the company in a research report on Friday, April 26th. Royal Bank of Canada cut their price objective on Teladoc Health from $25.00 to $18.00 and set an “outperform” rating for the company in a research report on Friday, April 26th. Cantor Fitzgerald initiated coverage on Teladoc Health in a research report on Thursday, February 29th. They issued an “overweight” rating and a $22.00 price objective for the company. Finally, Bank of America cut their price objective on Teladoc Health from $16.50 to $13.50 and set a “neutral” rating for the company in a research report on Tuesday, May 14th. Thirteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus price target of $18.22.

Teladoc Health Price Performance

The company has a quick ratio of 3.74, a current ratio of 3.82 and a debt-to-equity ratio of 0.67. The company has a fifty day simple moving average of $11.70 and a 200-day simple moving average of $15.87.

Teladoc Health (NYSE:TDOC) last issued its earnings results on Thursday, April 25th. The health services provider reported ($0.49) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.47) by ($0.02). The company had revenue of $646.13 million during the quarter, compared to analysts’ expectations of $637.31 million. Teladoc Health had a negative net margin of 8.90% and a negative return on equity of 10.13%. The firm’s quarterly revenue was up 2.7% compared to the same quarter last year. During the same quarter in the previous year, the company earned ($0.37) earnings per share. As a group, equities analysts expect that Teladoc Health, Inc. will post -1.05 earnings per share for the current fiscal year.

Insider Buying and Selling at Teladoc Health

In other news, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $132,115.59. Following the transaction, the insider now owns 86,070 shares of the company’s stock, valued at approximately $1,092,228.30. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. In other news, COO Michael Willem Waters sold 5,793 shares of the company’s stock in a transaction on Thursday, May 2nd. The stock was sold at an average price of $12.69, for a total value of $73,513.17. Following the transaction, the chief operating officer now owns 64,881 shares of the company’s stock, valued at approximately $823,339.89. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Laizer Kornwasser sold 10,411 shares of the company’s stock in a transaction on Thursday, May 2nd. The shares were sold at an average price of $12.69, for a total value of $132,115.59. Following the completion of the transaction, the insider now directly owns 86,070 shares in the company, valued at approximately $1,092,228.30. The disclosure for this sale can be found here. Insiders sold a total of 32,150 shares of company stock worth $392,913 in the last three months. 0.95% of the stock is owned by corporate insiders.

Hedge Funds Weigh In On Teladoc Health

Large investors have recently modified their holdings of the business. ICA Group Wealth Management LLC acquired a new position in Teladoc Health during the 4th quarter worth about $28,000. Hexagon Capital Partners LLC lifted its stake in Teladoc Health by 204.4% during the 4th quarter. Hexagon Capital Partners LLC now owns 1,586 shares of the health services provider’s stock worth $34,000 after acquiring an additional 1,065 shares in the last quarter. RIA Advisory Group LLC acquired a new position in Teladoc Health during the 4th quarter worth about $36,000. GAMMA Investing LLC acquired a new position in Teladoc Health during the 4th quarter worth about $41,000. Finally, Principal Securities Inc. acquired a new position in Teladoc Health during the 4th quarter worth about $45,000. Institutional investors and hedge funds own 76.82% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.